Found: 4
Select item for more details and to access through your institution.
Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells.
- Published in:
- Breast Cancer Research, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13058-022-01515-1
- By:
- Publication type:
- Article
Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2380, doi. 10.3390/cancers14102380
- By:
- Publication type:
- Article
ERα/PR crosstalk is altered in the context of the ERα Y537S mutation and contributes to endocrine therapy-resistant tumor proliferation.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00601-7
- By:
- Publication type:
- Article
Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancer.
- Published in:
- Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-024-01843-4
- By:
- Publication type:
- Article